Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jin-Ching Lin

Showing results (121-130 of 135) with videos related to

Pageof 14
Sort By:
Cancer Medicine|January 3, 2024
Is elective neck dissection justified in cT2N0M0 oral cavity cancer defined according to the AJCC eighth edition staging system?Tsung-Ming Chen, Shyuang-Der Terng, Li-Yu Lee, et al.
BMC Cancer|October 25, 2024
Prognostic significance of adjuvant therapy and specific radiation dosages in Taiwanese patients with oral cavity cancer and extra-nodal extension: a nationwide cohort studyYao-Te Tsai, Wen-Cheng Chen, Yu-Wen Wen, et al.
The Lancet. Oncology|December 1, 2022
International recommendations for plasma Epstein-Barr virus DNA measurement in nasopharyngeal carcinoma in resource-constrained settings: lessons from the COVID-19 pandemicVictor Ho-Fun Lee, Marlinda Adham, Wala Ben Kridis, et al.
Frontiers in Oncology|December 1, 2022
Optimizing margin status for improving prognosis in patients with oral cavity squamous cell carcinoma: A retrospective study from the two highest-volume Taiwanese hospitalsChun-Ta Liao, Li-Yu Lee, Shu-Ru Lee, et al.
Cancer Medicine|August 5, 2024
Prognostic impact of bridge or neoadjuvant induction chemotherapy in patients with resected oral cavity cancer: A nationwide cohort studyCheng-Lung Hsu, Yu-Wen Wen, Hung-Ming Wang, et al.
Oral Oncology|April 4, 2025
Pathological primary tumor status, rather than adjuvant therapy, predicts survival outcomes in pT1-3N1M0 oral cavity squamous cell carcinoma: A nationwide cohort studyYao-Te Tsai, Yu-Wen Wen, Tsung-You Tsai, et al.
International Journal of Radiation Oncology, Biology, Physics|July 15, 2024
International Recommendations on Postoperative Management for Potentially Resectable Locally Recurrent Nasopharyngeal CarcinomaJi-Shi Li, Pierre Blanchard, Charlene H L Wong, et al.
Oral Oncology|January 22, 2025
Prognostic significance of diagnosis-to-surgery interval in oral cavity squamous cell carcinoma: A nationwide studyChung-Jan Kang, Yu-Wen Wen, Chien-Yu Lin, et al.
Oral Oncology|January 29, 2025
Is postoperative adjuvant therapy necessary for pT3N0 oral cavity squamous cell carcinoma?Chun-Hung Hua, Jin-Ching Lin, Yu-Wen Wen, et al.
Oral Oncology|March 25, 2023
Indications for elective neck dissection in cT1N0M0 oral cavity cancer according to the AJCC eight edition: A nationwide studyChih-Yen Chien, Cheng Ping Wang, Li-Yu Lee, et al.
Pageof 14

Showing results (121-130 of 135) with videos related to

Sort By:
Pageof 14
Cancer Medicine|January 3, 2024
Is elective neck dissection justified in cT2N0M0 oral cavity cancer defined according to the AJCC eighth edition staging system?Tsung-Ming Chen, Shyuang-Der Terng, Li-Yu Lee, et al.
BMC Cancer|October 25, 2024
Prognostic significance of adjuvant therapy and specific radiation dosages in Taiwanese patients with oral cavity cancer and extra-nodal extension: a nationwide cohort studyYao-Te Tsai, Wen-Cheng Chen, Yu-Wen Wen, et al.
The Lancet. Oncology|December 1, 2022
International recommendations for plasma Epstein-Barr virus DNA measurement in nasopharyngeal carcinoma in resource-constrained settings: lessons from the COVID-19 pandemicVictor Ho-Fun Lee, Marlinda Adham, Wala Ben Kridis, et al.
Frontiers in Oncology|December 1, 2022
Optimizing margin status for improving prognosis in patients with oral cavity squamous cell carcinoma: A retrospective study from the two highest-volume Taiwanese hospitalsChun-Ta Liao, Li-Yu Lee, Shu-Ru Lee, et al.
Cancer Medicine|August 5, 2024
Prognostic impact of bridge or neoadjuvant induction chemotherapy in patients with resected oral cavity cancer: A nationwide cohort studyCheng-Lung Hsu, Yu-Wen Wen, Hung-Ming Wang, et al.
Oral Oncology|April 4, 2025
Pathological primary tumor status, rather than adjuvant therapy, predicts survival outcomes in pT1-3N1M0 oral cavity squamous cell carcinoma: A nationwide cohort studyYao-Te Tsai, Yu-Wen Wen, Tsung-You Tsai, et al.
International Journal of Radiation Oncology, Biology, Physics|July 15, 2024
International Recommendations on Postoperative Management for Potentially Resectable Locally Recurrent Nasopharyngeal CarcinomaJi-Shi Li, Pierre Blanchard, Charlene H L Wong, et al.
Oral Oncology|January 22, 2025
Prognostic significance of diagnosis-to-surgery interval in oral cavity squamous cell carcinoma: A nationwide studyChung-Jan Kang, Yu-Wen Wen, Chien-Yu Lin, et al.
Oral Oncology|January 29, 2025
Is postoperative adjuvant therapy necessary for pT3N0 oral cavity squamous cell carcinoma?Chun-Hung Hua, Jin-Ching Lin, Yu-Wen Wen, et al.
Oral Oncology|March 25, 2023
Indications for elective neck dissection in cT1N0M0 oral cavity cancer according to the AJCC eight edition: A nationwide studyChih-Yen Chien, Cheng Ping Wang, Li-Yu Lee, et al.
Pageof 14